Accepted Manuscript Collagen-silica bio-composite enriched with Cynodon dactylon extract for tissue repair and regeneration
Ramesh Kannan Perumal, Arun Gopinath, Thangam Ramar, Sathiamurthi Perumal, Dinesh Masilamani, Satiesh Kumar Ramadass, Madhan Balaraman PII: DOI: Reference:
S0928-4931(17)33354-4 doi:10.1016/j.msec.2018.06.050 MSC 8689
To appear in:
Materials Science & Engineering C
Received date: Revised date: Accepted date:
19 August 2017 17 May 2018 25 June 2018
Please cite this article as: Ramesh Kannan Perumal, Arun Gopinath, Thangam Ramar, Sathiamurthi Perumal, Dinesh Masilamani, Satiesh Kumar Ramadass, Madhan Balaraman , Collagen-silica bio-composite enriched with Cynodon dactylon extract for tissue repair and regeneration. Msc (2018), doi:10.1016/j.msec.2018.06.050
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT Collagen-Silica Bio-composite enriched with Cynodon dactylon extract for Tissue Repair and Regeneration Ramesh Kannan Perumal, Arun Gopinath, Thangam Ramar, Sathiamurthi Perumal, Dinesh Masilamani, Satiesh Kumar Ramadass, Madhan Balaraman*
CE
PT
ED
M
AN
US
CR
IP
T
CSIR - Central Leather Research Institute, Adyar, Chennai – 600020, Tamil Nadu, India
AC
Corresponding Author:
*Dr. B. Madhan, Principal Scientist CSIR- Central Leather Research Institute Adyar, Chennai 600020, India Tel: +91 44 24437169, Fax: +91 44 24911589 E-mail:
[email protected],
[email protected]
ACCEPTED MANUSCRIPT Abstract Development of biomaterials for tissue engineering applications is of great interest to meet the demand of different clinical requirements. The wound heal dressing biomaterials should necessarily contain well-defined therapeutic components and desirable physical,
T
chemical and biological properties to support optimal delivery of therapeutics at the site of
IP
the wound. In this study, we developed collagen-silica wound heal scaffold incorporated
CR
with the extract of Cynodon dactylon, characterized and evaluated for its wound heal
US
potential in vitro and in vivo against collagen (Col) and Collagen-silica (CS) scaffolds that served as controls. The prepared Collagen-Silica-Cynodon extract (CSCE) scaffold exhibits
AN
porous morphology with preferable biophysical, chemical, mechanical and mass transfer
M
properties besides its controlled biodegradation at the wound site. Stability of CSCE was found to be better than that of native collagen due to intermolecular interactions between
ED
collagen and constituents of C. dactylon as confirmed by FTIR analysis. Notably, in vitro
PT
biocompatibility assay using DAPI and Rhodamine 123 staining demonstrated that the proliferation of NIH3T3 fibroblast cells was better for CSCE when compared to the Col and
CE
CS scaffolds. In vivo wound healing experiments with full-thickness excision wounds in
AC
wistar rat model demonstrated that the wounds treated with CSCE showed accelerated healing with enhanced collagen deposition when compared to wounds treated with Col and CS scaffolds, and these studies substantiated the efficacy of CSCE scaffold for treating wounds. Keywords: Wound healing; Biomaterial; Collagen; Cynodon dactylon; Cell proliferation.
ACCEPTED MANUSCRIPT
1. Introduction Wound healing is a multifaceted skin regenerative process comprising the events of suppression of inflammatory reactions, migration, and proliferation of connective tissue
T
cells such as fibroblasts, collagen deposition, and remodeling of extracellular matrix (ECM)
IP
[1]. Effective wound dressings should induce conversion of cells from senescence to active
CR
state with an expression of optimal levels of collagen proteins and components of ECM but
US
inhibit processes facilitating further deterioration to achieve regeneration of healthy tissue. The therapeutic biomaterials are expected to have large surface area with porosity, and
AN
mass transfer features for enabling effective wound cover, aeration, exudate removal and
M
delivery of therapeutics, to facilitate proliferation of cells and controlled biodegradation for replacement with neo-tissues besides exhibiting low toxicity and high biocompatibility [2-
ED
5].
PT
Collagen-based biomaterials remain as a treatment of choice for wound therapy as they
CE
possess the chemotactic ability to activate fibroblasts cells and thereby encourage the deposition and organization of newly formed collagen to create an environment that
AC
fosters healing. Also, they have other preferable properties such as smooth adherence to the wound bed, the absorbance of wound exudates, preserving the moist environment, shielding against mechanical harm and preventing secondary bacterial infections, facilitating fibroblast growth and minimizing matrix metalloproteinase (MMP) activities, biocompatibility, and safety [6, 7]. It is reported that the functional aspects of collagen biomaterials were modified or improved by several strategies [8, 9]. We have earlier reported collagen and silica based collagen biomaterials for soft tissue engineering
ACCEPTED MANUSCRIPT applications, in which the ratio of collagen and silica were optimized to yield scaffolds with desired physical properties such as porosity, water uptake, and mechanical strength as well as biocompatibility and wound heal potentials [10]. Though there are reports on collagen scaffolds incorporated with growth factors [11], or antibiotics[12], they suffer limitations
T
due to the high cost of growth factors making them less affordable and the possibility of the
IP
emergence of antibiotic-resistant strains if antibiotics are used irrationally to prevent
CR
infections at the wound site [13]. Besides, the use of antibiotics in biomaterials does not
US
significantly support wound healing due to cytotoxicity to cells.
Phytoconstituents or extracts from medicinal plants offer an excellent opportunity to
AN
compliment the preparation of biotherapeutic materials by means of strengthening their
M
regenerative potentials such as angiogenesis, control of infection as well as inflammation with desirable features of high biocompatibility, safety, and affordability [14]. Cynodon
ED
dactylon L. (also known as Bermuda grass), belonging to the Poaceae family, is a perennial
PT
grass native to the warm temperate and tropical regions and it has many medicinal properties including antimicrobial, antiviral, anti-inflammatory [15], free radical
CE
scavenging potential and wound healing activity and these activities are attributed to
AC
phytochemicals such as hexadecanoic acid, apigenin, luteolin, quercetin etc. [16-18]. The use of C. dactylon, especially in reducing the inflammation as well as infection, angiogenesis and the associated wound healing benefits, has been widely reported in various traditional medicine systems [18, 19]. In this study, we attempt to develop Collagen-Silica-Cynodon extract (CSCE) scaffold comprising the collagen and phytoconstituents of C. dactylon for exhibiting synergistic and systemic effects on wound healing. The developed CSCE composite scaffolds were
ACCEPTED MANUSCRIPT characterized for biophysical, mechanical, biocompatibility and wound healing properties against Collagen and Collagen-Silica (CS) scaffolds in vitro and in vivo. 2. Materials and Methods
T
2.1. Materials, cells, and animals
IP
Collagenase Type 1A, 4′,6-Diamidine-2′-phenylindole dihydrochloride (DAPI), Rhodamine
CR
123 and reagents for MTT (3-(4, 5-dimethyl-thiazol-2-yl)- 2,5-di-phenyl-tetrazolium bromide) assay were purchased from Sigma-Aldrich (Bangalore, India). Tetraethoxysilane
US
(TEOS) was purchased from Alfa Aesar (Heysham, UK). All other chemicals used in this
AN
study were of analytical grade. Ultra-pure water from a Siemens water purification system was used in all experiments.
M
Forty-eight Wistar rats (female, six weeks old, 200 – 220 g) from Laboratory Animal
ED
Medicine (LAM) unit of Tamil Nadu Veterinary and Animal Sciences University (TANUVAS), Chennai were used in this study. The ambient temperature and relative humidity were
PT
maintained constant in the animal facility. Rats were acclimatized for one week before the
CE
experiments. Food and water were available ad libitum.
AC
2.2. Preparation of Cynodon dactylon extracts The extraction method, yield and chemical composition of cynodon plant have been reported elsewhere[18, 20]. The Cynodon dactylon plant was collected from Tiruvallur district of Tamil Nadu, India. The plant was washed with distilled water, shade dried and powdered with the help of domestic mixer. 10 g of the fine powder was soaked in 100 mL of 80% aqueous ethanol and stirred for 5 h and filtered using cheese cloth followed by centrifugation at 10,000 rpm for 15 min. After centrifugation, the ethanol was removed by
ACCEPTED MANUSCRIPT using rotary evaporator under reduced pressure at 35 °C, and the dried extract was placed at 4 °C until further use. The yield of the extract was about 8% of the crude powder (4 g of extract from 50 g of crude powder). The dried extract was dissolved in ethanol in a known concentration and used for further studies.
IP
T
2.3. Collagen extraction and scaffold preparation
CR
Acid solubilized collagen was isolated from bovine Achilles tendon according to the method of Tanaka et al. (1988) [21]. The collagen obtained was lyophilized, and redissolved in 0.05
US
M acetic acid at a final concentration of 4 mg/mL and stored at 4 °C. This solution was continuously stirred using Ultra-Turrax IKA T25 Homogenizer at 15,000 rpm to generate
AN
uniform foam. During homogenization, a drop of Triton X-100 was added as a frothing
M
agent. The collagen foam was poured immediately into a 90 mm sterile Petri dish and
ED
frozen at -80 °C overnight followed by freeze drying for 30 h continuously at temperature of -45 °C and pressure of 1 Pascal (Lark freeze dryer, perquin classic plus). The completely
PT
dried scaffolds were stored at 4 °C in airtight plastic containers and denoted as collagen
CE
sponge (Col).
Stober process involves sol-gel transmission assisted by the formation of silica from TEOS,
AC
which undergoes hydrolysis in the presence of acids and bases [22]. Acid catalyzed TEOS was added to the collagen solution, and the pH was adjusted to 6.0 using 0.32 M ammonium hydroxide to prepare collagen: silica (1:0.75 ratios) composite scaffold (CS) and other steps were followed as in the case of collagen sponge preparation. For the preparation of CSCE, 1.5 mL of Cynodon dactylon extract (CE) was added dropwise to the
ACCEPTED MANUSCRIPT above collagen and silica solution. Further steps were followed as mentioned above for the preparation of the scaffold. 2.4. Characterization of the scaffold Surface morphology of the prepared collagen and collagen composite scaffolds were
IP
T
studied using scanning electron microscopy (SEM, JEOL-JFC 6360), operated at an
CR
accelerating voltage of 5 kV. Then, the pore diameters of the SEM pictures of the scaffolds were analyzed using ImageJ (National Institute of Health, USA). The presence of functional
US
groups in the collagen (Col), collagen-silica (CS) and CSCE scaffolds was analyzed using an FTIR Spectrometer (Jasco, Japan) in the range of 500 – 4000 cm-1. Thermal stability of the
AN
prepared scaffolds was investigated using Differential Scanning Calorimetry (DSC Q200
M
Model, TA Instruments Inc., USA). DSC experiments were performed at temperatures
ED
ranging from 20 °C to 300 °C, at a controlled heating rate of 10 °C per min. In vitro enzymatic degradation studies of pure collagen and collagen, composite materials
PT
were performed with collagenase, and the release of hydroxyproline in the medium
CE
through degradation of collagen was analyzed according to the method of Woessner, 1961 [23]. Collagenase treatment was carried out in 0.04 M CaCl2 solution buffered at pH 7.2
AC
with 0.05 M Tris-HCl at 37 °C. The ratio of collagen and collagenase was maintained at 50:1 (w/w). The sampling was performed at desired time intervals (24 and 48 h). After incubation, the sample was immediately centrifuged at 2000 rpm at 4 °C for 10 min. An aliquot of the supernatant was hydrolyzed with 6 M HCl at 120 °C for 12 h. Degree of collagen degradation of collagen and collagen composite materials were assessed
ACCEPTED MANUSCRIPT spectrophotometrically through the measurement of hydroxyproline released in the supernatant. The Ethylene oxide (EO) sterilization was carried out at an external facility. For sterilization process, the scaffolds were placed in 35mm petri dishes and packaged in self-
T
sealing sterilization pouches. EO sterilization was performed by exposure to an EO
IP
atmosphere (concentration of 321g/m3), at a relative humidity of 65%, for 8h at 50 °C. The
CR
scaffolds were then aerated with warm airflow (45 °C) at atmospheric pressure for 48 h to
US
remove toxic EO.
AN
2.5. Porosity, Water Uptake, and Mechanical Properties
Scaffold porosity was measured using the liquid displacement technique [24]. Dimensions
M
of the sponges were measured using Vernier caliper, and the volume (V) was calculated.
ED
The pre-weighed scaffold (Wi) was immersed in a known volume of n-hexane in a graduated measuring cylinder for 48 h until it was saturated. The scaffold was removed,
PT
and the weight of the wet sponge was noted as (Wf), and the following equation was used
CE
to calculate the porosity of the scaffold:
AC
𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 (%) =
(𝑊𝑓 − 𝑊𝑖) × 100 (𝜌ℎ𝑒𝑥𝑎𝑛𝑒 × 𝑉)
where ρhexane is the density of hexane. The water uptake ability of the scaffold was studied to understand the diffusion of medium and nutrients into the scaffold. Pre-weighed scaffolds were immersed in phosphate buffered saline (PBS) at 37 °C for 2 h. The excess PBS solution is removed by gently blotting
ACCEPTED MANUSCRIPT the scaffolds on a filter paper and weighed. The water uptake ratio of the scaffolds was calculated using the formula: 𝑊𝑎𝑡𝑒𝑟 𝑈𝑝𝑡𝑎𝑘𝑒 (%) =
(𝑊𝑒𝑡 𝑤𝑒𝑖𝑔ℎ𝑡 − 𝐷𝑟𝑦 𝑤𝑒𝑖𝑔ℎ𝑡 ) × 100 ( 𝐷𝑟𝑦 𝑤𝑒𝑖𝑔ℎ𝑡 )
T
The mechanical properties of the scaffolds were tested using an Instron texture analyzer at
IP
room temperature (25 °C). Briefly, freeze- dried samples of 5 mm thickness were cut into 5
CR
cm x 1 cm size. The gauge length between the two grips was set at 15 mm, and the speed of
US
testing was set at 5 mm/min. The values of tensile strength and elongation at break were determined and were expressed as the mean ± standard deviation (n=3).
AN
2.6. Cell compatibility assays
M
The biocompatibility of synthesized scaffold was evaluated in vitro using MTT cell viability
ED
assay. Mouse embryonic fibroblasts (NIH 3T3 cells) were used as a reference cell line for this evaluation. The Ethylene oxide sterilized collagen (Col), CS and CSCE scaffolds (1 cm2 ×
PT
2 mm) were placed in 12-well plates which contained cells at a density of 1.5 × 105
CE
cells/well in 1 mL DMEM medium containing 10 % FBS, and the antibiotics penicillin, and streptomycin (100 IU/mL). The cells were cultured for 24 h in a humidified incubator with
AC
5% CO2 at 37 °C. The culture medium was replaced with fresh medium every 24 h. After treating the cells with developed scaffolds for about 1, 3and5 days, 500 μL MTT stock solutions (5 mg/mL in PBS) was added to each well and incubated for 4 h. The MTT solution was completely removed carefully and 250 μL DMSO was added to each well to dissolve the formazan blue crystals. The absorbance of the solution was measured using a microplate reader at 590 nm. The cell viability is determined as described below:
ACCEPTED MANUSCRIPT 𝐶𝑒𝑙𝑙 𝑉𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) =
(𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑠𝑎𝑚𝑝𝑙𝑒) × 100 ( 𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
Here, control refers to collagen scaffold (Col), and samples refer to the CS, CSCE scaffolds.
T
2.7. Cell viability and DAPI/Rhodamine 123
IP
The Col, CS, and CSCE scaffolds were placed onto 6-well plates, and 3T3 fibroblast cell
CR
suspension was added to the well (1.0 × 105 cells/well). After being incubated for 1, 3 and
US
5days, the cells were fixed with methanol (75 mL) and acetic acid (25 mL) (3:1) in PBS for 10 min. Following that, the cells were stained with DAPI, and Rhodamine 123 (Sigma-
AN
Aldrich, USA) and the stained cells were observed using an inverted fluorescence
M
microscope (Floid Cell imaging system, Invitrogen).
ED
2.8. F-actin filaments staining
A period of 24 h after the composite scaffolds was seeded with cells, F-actin staining was
PT
carried out to observe the cell interaction. In brief, the cells were initially fixed with 5%
CE
paraformaldehyde at 37°C for 15 min and permeabilized in 0.1% Triton X-100 at 37°C for 5 min. After permeation, cells were blocked with 10% fetal bovine serum at room for
45
AC
temperature
min.
The
cells
were
further
incubated
with
5
µM
FluoresceinIsothiocyanate (FITC)-phalloidin at room temperature for one hour. Further, the cell-scaffold constructs were washed with PBS, counterstained with DAPI for 30 min at room temperature for staining the nuclei and visualized under fluorescence microscope. 2.9. In vivo wound healing study
ACCEPTED MANUSCRIPT In vivo wound healing study was performed in a full thickness excision wound model. Female Wistar Rats (body weight range 200−220 g) were used for the study. All experimental protocols were approved by Institutional Animal Ethical Committee (Central Leather Research Institute, Chennai, India, IEAC No. 05/2014(b)) and NIH guidelines were
T
followed for proper use of animals for biomedical research. A total of 48 animals were
IP
divided into four groups, each consisting of 12 rats: group 1, CSCE treatment group; group
CR
2, CS treatment group; group 3, Collagen (Col) group; and group 4, untreated group
US
(Control). Each group of 12 rats was further divided into 3 subgroups of 4 rats each, which were sacrificed at predetermined time points for analysis. Animals were anesthetized by
AN
intraperitoneal injection of ketamine, at a dose of 50 mg/kg. The dorsal hair of the rats was removed, and the skin was disinfected with 70% ethanol. Full-thickness open excision
M
wounds of 2X2 cm were created using scalpel blade by excising the dorsal skin. In this
ED
study, we have used a square shaped silicone splint to avoid wound contraction. The
PT
wound was centered within the splint, which was fixed to the surrounding skin by suturing at corners to stabilize its position. The wound was photographed, and the initial wound
CE
area was traced using a transparent sheet. The scaffolds were applied on excised wounds
AC
and covered with absorbent gauze to hold the material in the wound area. On days 5, 10, and 15 of post-wounding (PW), four animals from each group were sacrificed by using CO2 chamber, wound area was traced, and regenerated skin was excised for histopathological investigation. The samples of excised regenerated skin were preserved by fixing them in 10% neutral buffered formalin and were examined by stained with hematoxylin and eosin (H&E) and Masson's trichrome staining methods.
ACCEPTED MANUSCRIPT
2.10 Statistical Analysis Data were expressed as mean ± SD. One-way ANOVA was performed to determine the statistical significance of the experiments. Differences were considered statistically
IP
T
significant at p < 0.05. Statistical analyses were performed using GraphPad Prism 5
CR
software. 3. Results and discussion
US
3.1. Physical and Mechanical Characteristics of Scaffolds
AN
The management of acute and chronic wounds represents a significant burden regarding pain, impaired quality of life of patients and direct costs of healthcare services. The
M
ultimate goal of wound management is to promote the development of healthy granulation
ED
tissue while minimizing the risk of inflammation, degradation of existing or regenerative
PT
tissue and opportunistic infection. Hence, in this study, an attempt has been made to prepare a wound healing composite material using collagen, silica and Cynodon plant
CE
extract (CE). The SEM images of the freeze-dried Col, CS, and CSCE composite scaffolds as
AC
shown in Fig. 1. We observed that the CSCE scaffold exhibited smooth surface with numerous evenly distributed pores of almost similar size when compared to the Col and CS scaffolds. The average pore diameters of the CS and CSCE scaffolds were found to be 364 and 327 µm, respectively. A slight reduction in the pore size of CSCE was observed against CS scaffold, and this was due to the presence of Cynodon extract in CSCE. We have earlier reported that the addition of silica to collagen improves the porosity of the collagen scaffold [10]. SEM images of CSCE scaffold reveals porous collagen fibrous mesh-like
ACCEPTED MANUSCRIPT appearance suggesting that the material can facilitate air exchange and oxygen diffusion at the wound site, easy absorption of wound exudates, cell attachment, proliferation and migration for tissue regeneration, and these properties are essential for wound heal dressing materials. The results were in agreement with porosity and water uptake analysis
T
of prepared scaffolds (Table 1 and Fig. 2). The porosity of the composite materials was
IP
measured by liquid displacement method in hexane at room temperature (Table 1). CS and
CR
CSCE scaffolds showed higher porosity at 89% and 93% respectively, whereas native Col
US
scaffold showed reduced porosity (81%). This result is in agreement with those reported earlier for CHCS composite scaffold [25]. The addition of extract in the CS scaffold did not
AN
reduce the porosity of the material, and this was due to the dispersion of phytochemicals evenly throughout the matrix. Water uptake capacity of the prepared scaffolds is examined
M
to evaluate the ability of these dressing materials to absorb exudates from the wound.
ED
Water uptake capacity of the CS was better than CSCE and Col scaffolds (Fig. 2), and this
PT
was due to the incorporation of silica in the CS composite [10]. The water holding capacity is an essential parameter for wound heal scaffold for preserving the moist environment at
CE
the wound site to promote rehydration of necrotic tissue for autolytic debridement, cell
AC
migration, cell-cell interaction, proliferation and migration of the fibroblast cells as well as collagen synthesis [26]. The mechanical properties of Col, CS, and CSCE scaffolds were presented in Table 1. Tensile strength and elongation at break of CS scaffold were reduced when compared to native collagen sponge due to the introduction of silica in the matrix. However, it could be seen that these properties for CSCE scaffold were increased when compared to Col scaffold due to the addition of Cynodon extract in the composite material and the extract has viscous in nature. The results of the study are in agreement with the
ACCEPTED MANUSCRIPT previous report on CS hybrid scaffold [10]. The collagen-based dressing materials should have sufficient mechanical strength suitable for handling the materials as well as for the desired clinical applications. 3.2. FT-IR and DSC analysis
IP
T
FT-IR spectrums of scaffolds are presented in Fig. 3a. The FTIR spectrum of native collagen
CR
showed the characteristics peaks of amide I, amide II and amide III at 1650 cm-1 (C=O stretching), 1554 cm-1 (N-H bending) and 1242 cm-1(C-N stretching)
US
respectively. The FTIR spectrum of CE showed a broad and intense absorption band around at 3350-3385 cm-1 correspond to the O-H stretching vibrations of polyphenols and
AN
phenolic acid. The CS composite showed a shift in OH stretching vibration to a lower wave
M
number and broadening, which indicates the hydrogen bonding interaction between
ED
collagen and silica. The silica is expected to exhibit non-covalent interactions viz., electrostatic and hydrogen bond interaction with collagen [27]. However, CSCE scaffold
PT
showed slight peak shift in the amide absorption region due to the interaction between Col
CE
and CE. We employed the DSC analysis to understand the thermal stability of native and composite scaffolds, and the thermogram was presented in Fig. 3b. DSC is a most widely
AC
used technique for measuring of denaturation temperature (Td), which is a measure of cross-linking density [28]. The denaturation temperature of the Col scaffold was found to be 74°C, which corresponds to the destabilization or denaturation of the triple helical structure of the collagen. However, the composite scaffold CS (91°C) and CSCE (110°C) showed remarkable improvement of the denaturation temperature. The improved denaturation temperature of the composite scaffold was due to the possible bonding
ACCEPTED MANUSCRIPT interactions between collagen and silica, and with the plant extract in the case of CSCE composite scaffold. 3.3. In vitro enzymatic degradation study The in vitro degradation behavior of Col, CS, and CSCE scaffolds upon collagenase treatment
IP
T
were investigated by monitoring the release of hydroxyproline in the solution at different
CR
time periods. The CSCE scaffold showed slower degradation when compared to native collagen (Fig. 4). About 44% and 52% of degradation were observed in the CSCE and CS
US
scaffold respectively, whereas the native collagen degraded rapidly to 62% at 24 h. After 48 h, the pure collagen scaffold showed 96% of degradation at ambient temperature
AN
conditions whereas the CSCE scaffold showed 63% of degradation indicating that the
M
addition of TEOS and CE has made them resistant to collagenolytic activity. Enzymatic
ED
stability of CSCE was enhanced significantly due to the presence of phytochemical constituents especially flavonoids in the CE. It is reported that flavonoids act as potential
PT
collagenase or MMP inhibitors and thus protect collagen proteins against the degradative
CE
activities of these enzymes [29, 30]. The addition of such substances in the scaffold would result in the overall increase in the measurable collagen concentration in healing tissue.
AC
The active secretion and destruction of collagen proteins are natural events in wound healing. In acute wounds, the secretion of MMPs during the early phase followed by secretion of MMP inhibitors to facilitate skin regeneration. However, the MMP levels are abnormally elevated in the chronic wound with down-regulation of expression of MMP inhibitors, i.e. tissue inhibitors of matrix metalloproteinases (TIMPs) [31]. The elevated ratio of MMPs to TIMPs leads to excessive extracellular matrix degradation as several MMPs have collagen hydrolytic properties. Besides anti-inflammatory and antimicrobial
ACCEPTED MANUSCRIPT effects, it was reported that luteolin and apigenin, the major phytochemicals of CE, exhibited inhibitory activity against a range of MMPs and collagenases [32-34]. The other predominant flavonoids of the plant C. dactylon such as quercetin and catechin interact and stabilize the collagen against proteolytic degradation besides stimulating collagen
T
synthesis [29, 30, 35, 36]. Since the CSCE of our study contains the Cynodon extract having
IP
the above phytoconstituents; the scaffold has the potential to accelerate healing of both
CR
acute and chronic wounds through the mechanisms mentioned above. Hence, it is
US
suggested that the use of the CSCE scaffold is more advantageous than the CS and conventional Col scaffolds.
AN
3.4. Biocompatibility and cell viability Analysis
M
The biocompatibility of developed scaffolds using proliferation rate of the cells was
ED
assessed using NIH 3T3 cells by MTT assay. It was observed that the NIH3T3 cells continued to proliferate on the surface of scaffolds, suggesting that the scaffolds were non-
PT
toxic to fibroblast cells. The results showed that the rate of cell proliferation was
CE
significantly higher in CS and CSCE scaffolds when compared to Col scaffold (Fig. 5). Both collagen and composite materials showed a time-dependent increase in cell proliferation at
AC
day 1, 3 and 5 of post seeding. The rate of cell proliferation was observed to be almost similar in all groups on 6 h, and day 1 of post seeding. However, it was observed that there were significant changes in the proliferation rate on day 3 and 5 among the scaffolds and there was a steady increase in the number of cells in CSCE group following the day 1, when compared to CS and Col materials (Fig. 5a). These results suggested that the porous and hydrophilic nature of CSCE scaffold has protective and proliferative effects on fibroblasts in addition to the chemotactic effects of collagen such as cell adhesion, cell differentiation, and
ACCEPTED MANUSCRIPT tissue regeneration. It is reported that the extract of C. dactylon has antibacterial activity [37]. Hence, the CSCE scaffold might prevent infection during the process of wound healing. Further, DAPI and Rh-123 staining were performed to detect metabolically active live cells grown on the prepared scaffolds at different time intervals such as day 1, 3 and 5. DAPI and
T
Rh-123 respectively form fluorescent complexes with nuclear material and active
IP
mitochondrial membranes of proliferative cells [38]. As seen in fluorescence microscopic
CR
images of Fig. 5(b-d), the number of live cells were significantly higher in CSCE scaffold
US
exposed group than controls. The live cells on the CSCE scaffold appeared to be well attached, networked and spread across the surface when compared to other groups as
AN
indicated by staining of intact mitochondria and nuclei of the cells. Thus, the composite
M
materials supported cell growth on the surfaces of composite materials, and the differences in cell distribution and viability among the groups were distinctly studied using these
ED
organelles-specific stains (Fig. 5b, c, and d). After 3 days of cell culture, the number of
PT
fibroblast cells attached to CS and CSCE was much higher than those of control (Fig. 5c). After 5 days of culture, cells completely covered the surface of CSCE scaffold whereas the
CE
cells in CS and Col scaffold groups did not show complete cover-up of the surface
AC
suggesting that the Cynodon extract significantly enhanced the proliferation of cells on the surface of CSCE scaffold (Fig. 5d). The porous structure of CSCE scaffold not only helped cell migration but also facilitated the exchange of oxygen and nutrients to cells, and it is essential for the construction of ECM and vascularization during the healing of wound [39].
ACCEPTED MANUSCRIPT 3.5. F-actin filaments FITC-phalloidin and DAPI staining were carried out to study the interaction of fibroblasts with composite scaffolds. Phalloidin is a bicyclic heptapeptide commonly used in imaging applications to selectively label filamentous actin in fixed cells [40]. Actin-tracker green
T
and nucleus-tracker blue were used for F-actin microfilaments and cell nucleus
IP
respectively. Staining of cells of 24 h culture showed the distribution of F-actin filaments
CR
(stained green) in the cytoplasm under a fluorescence microscope (Fig. 6). We observed
US
from the images that the density and morphology of fibroblasts were better in CSCE than CS and collagen scaffold groups. The cells supported by CSCE group revealed the
AN
distribution of a regular array of F-actin filaments stretched along the cell membranes, a
M
characteristic cytoskeletal feature of metabolically active fibroblasts of connective tissue, for facilitating cell-cell interaction and tissue regeneration. These results substantiated that
ED
CSCE scaffolds were not only biocompatible but also could potentially promote adhesion,
PT
proliferation, and migration of cells for effective regeneration of ECM.
CE
3.6. In vivo Wound Healing
The wound healing activity of Col, CS and CSCE scaffolds were assessed in rats by full
AC
thickness excision wound model. The CSCE scaffold showed accelerated wound healing from day 5 onwards when compared to CS and Col scaffolds (Fig. 7). On day 10 of post wounding, it was observed that the CSCE scaffold treated wound showed healing progress comparable to rest of the groups. The extent of reduction of wound size for CSCE and CS groups on day 10 was 74% and 63% respectively, whereas this was 56% and 48% for collagen and control groups, respectively. However, on the 15th day of post wounding (PW),
ACCEPTED MANUSCRIPT the rate of re-epithelization (wound closure) was observed as 59%, 75%, 87% and 94% for control, Col, CS, and CSCE respectively. Complete healing was observed on the 17th day of PW for CSCE groups, whereas it was 19 and 22 days for CS and Col treatment, respectively. Enhanced wound healing by CSCE could be attributed to anti-inflammatory, antimicrobial,
T
cell growth stimulating and tissue regenerative properties of CE and collagen constituents
IP
[15, 37]. Histological examinations were carried out on newly formed, healthy and healed
CR
tissues to analyze the collagen deposition, neovascularization, and re-epithelization. H&E
US
stained skin sections of control and collagen composite scaffold treatments at different days intervals are presented in Fig. 8. It was noteworthy that control group, CS, and Col
AN
scaffolds exhibited some inflammatory cells after 5 days of PW. However, CSCE scaffold group showed some fibroblasts cells along with few neutrophils and macrophages
M
indicating the progress of healing. The control group showed moderate inflammation after
ED
10 days whereas the absence of inflammatory cells and a few fibroblasts were observed in
PT
other groups. On day 15, the appearance of numerous fibroblasts accompanied by organized collagen deposition, epithelization and neovascularization were observed in all
CE
groups, and more particularly, these events were more pronounced in CSCE than other
AC
treatment groups. According to the report of Soraya et al. (2015) phytochemicals present in the aqueous extract of C. dactylon exhibited angiogenesis effect while reducing inflammation, which was advantageous properties for wound healing [19]. Saroja et al. reported that the aqueous extract of C. dactylon accelerated the activity of wound healing in an animal model with some basic physical parameters [41]. Collagen synthesis and deposition were the essential characteristics in tissue regeneration, and it is critical for the structure and function of healthy skin. Fig. 9 depicts the Masson’s
ACCEPTED MANUSCRIPT trichrome staining of the regenerated skin at different time intervals. On the day 5, the test groups exhibited the little amount of collagen deposition when compared to control. On the day 10, a large number of uniformly arranged thick collagen bundles as well as tissue granulation appeared in the regenerating wound area treated with CSCE scaffold when
T
compared to other groups. Furthermore, the formation of epidermis was complete, and the
IP
newly formed epidermis was connected with the dermis. The bioactive compounds present
CR
in C. dactylon include phenolic acid, flavonoids and triterpenes support wound healing
US
activity through anti-oxidative activity and inhibition of collagenases. 4. Conclusion
AN
In this paper, we have presented a novel collagen composite material incorporated with
M
Cynodon dactylon extract having wound healing potential. The prepared CSCE scaffold
ED
showed superior porous structure, water uptake, mechanical properties and biostability than native collagen. In vitro studies revealed that the scaffold promoted cell-cell
PT
interaction, cell adhesion and proliferation of fibroblasts making the scaffold most suitable
CE
substrate for skin tissue engineering. In vivo studies revealed that CSCE scaffolds stimulated collagen deposition and enhanced the rate of wound healing. These results
AC
substantiated the tissue regeneration property of CSCE scaffold which could serve as an ideal and alternative biomaterial for the treatment of chronic wounds. Acknowledgments The authors are grateful to the Council of Scientific and Industrial Research (CSIR) for the providing financial support under the M2D XII plan project (CSC 0134). Author RKP thank UGC for Postdoctoral Research Fellowship.
ACCEPTED MANUSCRIPT References [1] P. Martin, Wound healing--aiming for perfect skin regeneration, Science, 276 (1997) 7581. [2] J.S. Lee, G.H. Jin, M.G. Yeo, C.H. Jang, H. Lee, G.H. Kim, Fabrication of electrospun polycaprolactone/fucoidan
for
tissue
T
comprising
regeneration,
IP
biocomposites
CR
Carbohydrate polymers, 90 (2012) 181-188.
[3] M. Varley, S. Neelakantan, T. Clyne, J. Dean, R. Brooks, A. Markaki, Cell structure,
US
stiffness and permeability of freeze-dried collagen scaffolds in dry and hydrated states,
AN
Acta biomaterialia, 33 (2016) 166-175.
[4] T.A. Martin, S.R. Caliari, P.D. Williford, B.A. Harley, R.C. Bailey, The generation of patterns
in
highly
porous
M
biomolecular
collagen-GAG
scaffolds
using
direct
ED
photolithography, Biomaterials, 32 (2011) 3949-3957.
PT
[5] Y. Liu, L. Ma, C. Gao, Facile fabrication of the glutaraldehyde cross-linked collagen/chitosan porous scaffold for skin tissue engineering, Materials Science and
CE
Engineering: C, 32 (2012) 2361-2366.
AC
[6] C.H. Lee, A. Singla, Y. Lee, Biomedical applications of collagen, International journal of pharmaceutics, 221 (2001) 1-22. [7] J.A. Ramshaw, Y.Y. Peng, V. Glattauer, J.A. Werkmeister, Collagens as biomaterials, Journal of Materials Science: Materials in Medicine, 20 (2009) 3.
ACCEPTED MANUSCRIPT [8] M.F. Desimone, C. Hélary, G. Mosser, M.-M. Giraud-Guille, J. Livage, T. Coradin, Fibroblast encapsulation in hybrid silica–collagen hydrogels, Journal of Materials Chemistry, 20 (2010) 666-668. [9] S. Heinemann, C. Heinemann, M. Jager, J. Neunzehn, H. Wiesmann, T. Hanke, Effect of
T
silica and hydroxyapatite mineralization on the mechanical properties and the
IP
biocompatibility of nanocomposite collagen scaffolds, ACS applied materials & interfaces, 3
CR
(2011) 4323-4331.
US
[10] S. Perumal, S. kumar Ramadass, A. Gopinath, B. Madhan, G. Shanmugam, J. Rajadas, A.B. Mandal, Altering the concentration of silica tunes the functional properties of collagen–
AN
silica composite scaffolds to suit various clinical requirements, Journal of the mechanical
M
behavior of biomedical materials, 52 (2015) 131-138.
ED
[11] A.K. Ekaputra, G.D. Prestwich, S.M. Cool, D.W. Hutmacher, The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly (ɛ-caprolactone)/collagen
PT
fibers and hyaluronic acid hydrogel, Biomaterials, 32 (2011) 8108-8117.
CE
[12] S.-N. Park, J.K. Kim, H. Suh, Evaluation of antibiotic-loaded collagen-hyaluronic acid
AC
matrix as a skin substitute, Biomaterials, 25 (2004) 3689-3698. [13] D. Campoccia, L. Montanaro, P. Speziale, C.R. Arciola, Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use, Biomaterials, 31 (2010) 6363-6377. [14] P. Jithendra, A.M. Rajam, T. Kalaivani, A.B. Mandal, C. Rose, Preparation and characterization of aloe vera blended collagen-chitosan composite scaffold for tissue engineering applications, ACS applied materials & interfaces, 5 (2013) 7291-7298.
ACCEPTED MANUSCRIPT [15] K.S. Murali, S. Sivasubramanian, S. Vincent, S.B. Murugan, B. Giridaran, S. Dinesh, P. Gunasekaran, K. Krishnasamy, R. Sathishkumar, Anti—chikungunya activity of luteolin and apigenin rich fraction from Cynodon dactylon, Asian Pacific journal of tropical medicine, 8 (2015) 352-358.
T
[16] Y. Chaudhari, H.R. Mody, V.B. Acharya, Antibacterial activity of Cynodon dactylon on
CR
Pharmaceutical Studies and Research, 1 (2011) 16-20.
IP
different bacterial pathogens isolated from clinical samples, International Journal of
US
[17] R. Jananie, V. Priya, K. Vijayalakshmi, Determination of bioactive components of
AN
Cynodon dactylon by GC-MS analysis, NY Sci J, 4 (2011) 16-20. [18] T.K. Biswas, S. Pandit, S. Chakrabarti, S. Banerjee, N. Poyra, T. Seal, Evaluation of
M
Cynodon dactylon for wound healing activity, Journal of ethnopharmacology, 197 (2017)
ED
128-137.
[19] H. Soraya, M. Moloudizargari, S. Aghajanshakeri, S. Javaherypour, A. Mokarizadeh, S.
PT
Hamedeyazdan, H.E.G. Ghaleh, P. Mikaili, A. Garjani, Angiogenic effect of the aqueous
CE
extract of Cynodon dactylon on human umbilical vein endothelial cells and granulation
AC
tissue in rat, DARU Journal of Pharmaceutical Sciences, 23 (2015) 10. [20] D. Khlifi, E.A. Hayouni, A. Valentin, S. Cazaux, B. Moukarzel, M. Hamdi, J. Bouajila, LC– MS analysis, anticancer, antioxidant and antimalarial activities of Cynodon dactylon L. extracts, Industrial crops and products, 45 (2013) 240-247. [21] S. Tanaka, G. Avigad, E. Eikenberry, B. Brodsky, Isolation and partial characterization of collagen chains dimerized by sugar-derived cross-links, Journal of Biological Chemistry, 263 (1988) 17650-17657.
ACCEPTED MANUSCRIPT [22] S. Radin, P. Ducheyne, T. Kamplain, B. Tan, Silica sol‐gel for the controlled release of antibiotics. I. Synthesis, characterization, and in vitro release, Journal of Biomedical Materials Research Part A, 57 (2001) 313-320. [23] J.F. Woessner, The determination of hydroxyproline in tissue and protein samples
T
containing small proportions of this imino acid, Archives of biochemistry and biophysics,
CR
IP
93 (1961) 440-447.
[24] Y. Zhang, M. Zhang, Synthesis and characterization of macroporous chitosan/calcium
US
phosphate composite scaffolds for tissue engineering, Journal of biomedical materials
AN
research, 55 (2001) 304-312.
[25] S.K. Ramadass, S. Perumal, A. Gopinath, A. Nisal, S. Subramanian, B. Madhan, Sol–gel
M
assisted fabrication of collagen hydrolysate composite scaffold: A novel therapeutic
ED
alternative to the traditional collagen scaffold, ACS applied materials & interfaces, 6 (2014) 15015-15025.
PT
[26] P. Zahedi, I. Rezaeian, S.O. Ranaei‐Siadat, S.H. Jafari, P. Supaphol, A review on wound
CE
dressings with an emphasis on electrospun nanofibrous polymeric bandages, Polymers for
AC
Advanced Technologies, 21 (2010) 77-95. [27] X. Ye, Y. Zhou, Y. Sun, J. Chen, Z. Wang, Structure and infrared emissivity of collagen/SiO 2 composite, Applied Surface Science, 254 (2008) 5975-5980. [28] N. Danilov, N.Y. Ignatieva, E. Iomdina, S. Semenova, G. Rudenskaya, T. Grokhovskaya, V. Lunin, Stabilization of scleral collagen by glycerol aldehyde cross-linking, Biochimica et Biophysica Acta (BBA)-General Subjects, 1780 (2008) 764-772.
ACCEPTED MANUSCRIPT [29] T. Stipcevic, J. Piljac, D.V. Berghe, Effect of different flavonoids on collagen synthesis in human fibroblasts, Plant foods for human nutrition, 61 (2006) 27-32. [30] B.Y. Sin, H.P. Kim, Inhibition of collagenase by naturally-occurring flavonoids, Archives of pharmacal research, 28 (2005) 1152-1155.
IP
T
[31] C.A. Fleck, R. Simman, Modern collagen wound dressings: function and purpose, The
CR
Journal of the American College of Certified Wound Specialists, 2 (2010) 50-54. [32] B.-J. Kang, J. Ryu, C.J. Lee, S.-C. Hwang, Luteolin inhibits the activity, secretion and gene
US
expression of MMP-3 in cultured articular chondrocytes and production of MMP-3 in the
AN
rat knee, Biomolecules & therapeutics, 22 (2014) 239.
[33] J.-H. Lee, H.Y. Zhou, S.Y. Cho, Y.S. Kim, Y.S. Lee, C.S. Jeong, Anti-inflammatory
M
mechanisms of apigenin: inhibition of cyclooxygenase-2 expression, adhesion of monocytes
ED
to human umbilical vein endothelial cells, and expression of cellular adhesion molecules,
PT
Archives of pharmacal research, 30 (2007) 1318-1327. [34] K. Horvathova, L. Novotny, D. Tothova, A. Vachalkova, Determination of free radical
CE
scavenging activity of quercetin, rutin, luteolin and apigenin in H~ 2O~ 2-treated human
AC
ML cells K562, Neoplasma, 51 (2004) 395-399. [35] S.D. Muthukrishnan, A. Kaliyaperumal, A. Subramaniyan, Identification and determination of flavonoids, carotenoids and chlorophyll concentration in Cynodon dactylon (L.) by HPLC analysis, Natural product research, 29 (2015) 785-790. [36] X. Yang, D. Wu, Z. Du, R. Li, X. Chen, X. Li, Spectroscopy study on the interaction of quercetin with collagen, Journal of agricultural and food chemistry, 57 (2009) 3431-3435.
ACCEPTED MANUSCRIPT [37] S. Ahmed, M. Reza, S. Haider, A. Jabbar, Antimicrobial activity of Cynodon dactylon, Fitoterapia, 65 (1994) 463-464. [38] G. Kroemer, J.C. Reed, Mitochondrial control of cell death, Nature medicine, 6 (2000) 513.
Biomedical Applications of
CR
Multiscale fibrous scaffolds in regenerative medicine,
IP
T
[39] S. Srinivasan, R. Jayakumar, K. Chennazhi, E.J. Levorson, A.G. Mikos, S.V. Nair,
Polymeric Nanofibers, Springer2011, pp. 1-20.
US
[40] A. Filaments, Effects of cytochalasin and phalloidin on actin, The Journal of cell biology,
AN
105 (1987) 1473-1478.
[41] M. Saroja, R. Shanti, S. Annapoorani, Wound Healing Activity of Flavonoid Fraction of
M
Cynodon Dactylon in Swiss Albino Mice. 2, 2012, International Research Journal of
PT
ED
Pharmacy, 3 230-231.
Table
CE
Table 1 Porosity and mechanical properties of Col, CS and CSCE scaffolds. Experiments are
AC
performed in triplicates, the *p < 0.05, considered to be statistically significant with control group (Col)
Scaffold
Col
Porosity (%)
81±1.62
Mechanical Properties Tensile Strength (Mpa)
Elongation at Break (%)
0.88 ± 0.05
14.3 ± 0.56
ACCEPTED MANUSCRIPT 89±1.52*
0.53 ± 0.04*
10.8 ± 0.43*
CSCE
93±1.86*
0.92 ± 0.03*
15.9 ± 0.93*
M
AN
US
CR
IP
T
CS
ED
Figure Legends
Fig. 1 Photographic and SEM morphology of Col, CS and CSCE scaffolds at magnifications of
PT
40X. Pore size measurement of scaffold using ImageJ software.
CE
Fig. 2 In vitro water uptake ability of Col, CS and CSCE scaffolds. Data are expressed as
AC
mean ± SD (n = 5).
Fig. 3 (a) FTIR spectra of Collagen, CS, and Cynodon extract and CSCE scaffolds; (b) DSC thermogram of Col, CS and CSCE scaffolds Fig. 4 In vitro enzymatic degradation of Col, CS and CSCE scaffolds at different time intervals. A significant difference (**p < 0.01) in collagen degradation was measured between CS, CSCE, and collagen group.
ACCEPTED MANUSCRIPT Fig. 5 (a). In vitro biocompatibility of scaffolds by MTT assay. Values are expressed as mean ± SD and the level of significance is expressed as *and ** corresponding to p < 0.05 and p < 0.01, respectively compared with the corresponding control group. Fluorescence microscopy images (400X magnifications) of DAPI and Rh-123 stained 3T3 mouse
T
fibroblasts cells on developed scaffolds at different time intervals (b) Day 1, (c) Day 3 and
CR
indicates active mitochondrial membranes of cells.
IP
(d) Day 5. DAPI staining (blue color) shows nucleus and Rh-123 staining (green color)
US
Fig. 6 Fluorescence images of the cytoskeleton and nuclei of NIH3T3 fibroblasts cultured on Col, CS and CSCE scaffolds for 24 h. Actin microfilaments (green) and cell nuclei (blue)
AN
were visualized by FITC-phalloidin and DAPI respectively (The measurement of scale is 50
M
µm).
ED
Fig. 7 Photographs of the Col, CS, CSCE and control (untreated) wounds. Each wound shown here is representative of four rats per group on the given day.
PT
Fig. 8 Hematoxylin and Eosin stained sections of the regenerated skins of control and
CE
experimental animal groups on 5th, 10th and 15th days. Arrow (Yellow in colour) indicates the fibroblasts cells of granulated tissues. The magnification is 20X with 50 µm scale bar.
AC
Fig. 9 Masson’s trichrome staining of skin tissues treated with Col, CS, and CSCE and an untreated control group of animals. The magnification is 20X with 50 µm scale bar.
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
M
AN
US
CR
IP
T
Fig. 1.
ACCEPTED MANUSCRIPT
AN
US
CR
IP
T
Fig. 2.
AC
CE
PT
ED
M
Fig. 3.
ACCEPTED MANUSCRIPT
AN
US
CR
IP
T
Fig. 4.
AC
CE
PT
ED
M
Fig. 5.
ACCEPTED MANUSCRIPT
M
AN
US
CR
IP
T
Fig. 6.
AC
CE
PT
ED
Fig. 7.
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
M
AN
US
CR
IP
T
Fig. 8.
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
M
AN
US
CR
IP
T
Fig. 9.
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
M
AN
US
CR
IP
T
Graphical Abstract
ACCEPTED MANUSCRIPT Highlights Collagen based biomaterial have many application in the field tissue engineering
The developed CSCE scaffolds support the proliferation of fibroblasts cells
The stability of CSCE was better than native collagen scaffold
CSCE scaffold has the potential for use of wound healing applications
AC
CE
PT
ED
M
AN
US
CR
IP
T